Treatment · Repurposed drug
Metformin
One of the few long COVID findings from a large randomized trial: a cheap diabetes drug, taken early in infection, lowered the chance of developing long COVID by about 40 percent. The crucial caveat is that this is prevention, not a cure for established illness.
Short version: in a randomized trial, a 14-day metformin course during acute COVID cut later long COVID by roughly 40 percent. It is prevention during infection, not a treatment for established long COVID.
An old drug, a new use
Metformin, a cheap and familiar diabetes drug, has antiviral and anti-inflammatory effects beyond blood sugar. The question was whether taking it early in infection could head off long COVID.1
What the trial showed
In the COVID-OUT randomized trial, a 14-day course started during acute infection cut long COVID over the next 10 months: cumulative incidence about 6.3% with metformin versus 10.4% with placebo, roughly a 40% relative reduction. Ivermectin and fluvoxamine did not help.1
randomized, prevention
The key limit
This is prevention, taken during acute COVID, not a treatment for people who already have long COVID. Whether metformin helps established long COVID is a separate, unanswered question.
What we don't know
Honest about the edges of the evidence. These are open questions, not settled answers.
- Whether metformin helps people who already have long COVID.
- Whether it works in those previously infected or of lower body weight.
- The mechanism of the protection.
References
Every reference is free to read in full.